Evidence map›Paper›PMID 38791132›Full record

ArticleInternational journal of molecular sciences2024

Restoration of

Yulia Makusheva, Elena Goncharova, Victoria Bets, Anastasya Korel, Elena Arzhanova, Ekaterina Litvinova

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Unveiling the potential ofFrontiers in microbiology · 2025
    Review
  2. Caffeic acid phenethyl ester attenuatesJournal of medicine and life · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yulia MakushevaFaculty of Physical Engineering, Novosibirsk State Technical University, 630073 Novosibirsk, Russia.
Elena GoncharovaFaculty of Physical Engineering, Novosibirsk State Technical University, 630073 Novosibirsk, Russia.
Victoria BetsFaculty of Physical Engineering, Novosibirsk State Technical University, 630073 Novosibirsk, Russia.
Anastasya KorelFaculty of Physical Engineering, Novosibirsk State Technical University, 630073 Novosibirsk, Russia.ORCID 0000-0002-2945-3658
Elena ArzhanovaDepartment of Natural Sciences, Novosibirsk State University, 630090 Novosibirsk, Russia.
Ekaterina LitvinovaFaculty of Physical Engineering, Novosibirsk State Technical University, 630073 Novosibirsk, Russia.ORCID 0000-0001-6398-7154

Funding

Russian Science Foundation 23-26-00270
6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) is a multifactorial disease involving the interaction of the gut microbiota, genes, host immunity, and environmental factors. Dysbiosis in IBD is associated with pathobiont proliferation, so targeted antibiotic therapy is a rational strategy. When restoring the microbiota with probiotics, it is necessary to take into account the mutual influence of co-cultivated microorganisms, as the microbiota is a dynamic community of species that mediates homeostasis and physiological processes in the intestine. The aim of our study was to investigate the recovery efficacy of two potential probiotic bacteria,

Indexed as

Anti-Bacterial AgentsDysbiosisEnterococcus faecalisLactobacillus johnsoniiProbioticsAnimalsDisease Models, AnimalGastrointestinal MicrobiomeInflammatory Bowel DiseasesMiceMice, KnockoutMucin-2Anti-Bacterial AgentsMuc2 protein, mouseMucin-2antibiotic treatmentbacteria recoveryIBDmicrobiotaprotozoa

Identifiers

PMID38791132
PMCPMC11120941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.